Imagine walking into an emergency department with chest pain. You are worried about a heart attack. Doctors need to know if you are safe to go home or if you need urgent care. This new research compares two tools doctors use to make that decision. The study looked at 14,862 patients who came to the emergency department with acute chest pain. These are people who feel pain in their chest and need immediate medical attention. The researchers wanted to see which tool was better at predicting serious problems within 30 days. The main problem they watched for was death, a heart attack, or needing urgent surgery to open a blocked artery. This is called major adverse cardiac events or MACE. The study found that the HEART score was significantly better at finding the patients who actually had a heart problem. It missed fewer dangerous cases than the other tool. This means fewer people with heart attacks might be sent home by mistake. The HEART score also worked very well for patients from Eastern populations. The researchers checked the numbers carefully to make sure the results were real. They found that the HEART score had a sensitivity ratio of 1.09 compared to the other score. This number means it found more of the sick patients. A lower negative likelihood ratio also showed the HEART score was good at ruling out heart attacks. When a test has a low negative likelihood ratio, it means if the test is negative, you are very likely safe. The HEART score showed a value of 0.08 while the other score showed 0.42. This is a big difference that helps doctors feel more confident. However, the HEART score had lower specificity. This means it might flag more people as high risk than necessary. The other tool was better at identifying only the very high-risk cases. This is important because doctors need to balance safety with not overloading the hospital with low-risk patients. The study did not report any safety concerns or side effects because these are just math tools used for testing. There were no drugs involved. The researchers noted that standardizing how they measure heart muscle damage is critical for future use. This means doctors must use the same tests everywhere to get accurate results. Patients should not overreact to this single study. It is a review of many different studies. It gives a clearer picture but is not a guarantee for every single person. For now, this research supports using the HEART score to safely discharge low-risk individuals. It also suggests using the other tool to find the few high-risk cases that need intervention. This helps keep patients safe without keeping them in the hospital longer than needed.
HEART score sensitivity 0.96 vs GRACE 0.88 for 30-day MACE in ED chest painHEART score better than GRACE at spotting heart attack risk in emergency room patients
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis evaluated the diagnostic performance of the HEART score versus the GRACE score in emergency department (ED) patients with acute chest pain. The analysis pooled data from a total sample size of 14,862 patients across various settings, focusing on the emergency department population. The primary outcome was 30-day major adverse cardiac events (MACE), defined as death, myocardial infarction, and urgent revascularization.
The intervention was the HEART score, and the comparator was the GRACE score. Specific dosing or protocol details for these scores were not reported in the input. The follow-up period for all outcomes was 30 days.
For the primary outcome, the HEART score demonstrated significantly higher sensitivity than the GRACE score, with an effect size of 0.96 (95% CI: 0.94-0.98) versus 0.88 (95% CI: 0.85-0.91). The ratio for sensitivity was 1.09 (95% CI: 1.05-1.14). The HEART score also showed a lower negative likelihood ratio (NLR) of 0.08 (95% CI: 0.03-0.17) compared to the GRACE score's NLR of 0.42 (95% CI: 0.39-0.46). However, the HEART score had lower specificity (0.50, 95% CI: 0.41-0.60) than the GRACE score (0.61, 95% CI: 0.58-0.64). The area under the curve (AUC) for discriminative power was superior for the HEART score at 0.80 (95% CI: 0.77-0.84) versus 0.72 (95% CI: 0.69-0.75) for the GRACE score, with a ratio of 1.11 (95% CI: 1.07-1.15).
Key secondary outcomes included subgroup analysis in Eastern populations, which confirmed the HEART score's advantage in sensitivity, with a sensitivity ratio of 1.57 (95% CI: 1.27-1.93). No other secondary outcomes were reported.
Safety and tolerability findings were not reported for either score, including adverse events, serious adverse events, and discontinuations.
These results can be compared to prior landmark studies in risk stratification for acute chest pain, though specific comparisons were not detailed in the input. The HEART score's higher sensitivity aligns with its established role in identifying low-risk patients for safe discharge.
Key methodological limitations include the critical need for standardization of troponin assays and MACE definitions for future implementation, as noted in the limitations section. Potential biases were not explicitly reported, but heterogeneity in study designs and populations could influence results.
Clinical implications are that the HEART score supports its utility for safe discharge of low-risk individuals, while the GRACE score's higher specificity may aid in identifying high-risk cases requiring intervention. This informs practice decisions by highlighting the trade-offs between sensitivity and specificity for risk stratification.
Unanswered questions remain regarding the optimal use of these scores in specific subpopulations, the impact of standardized protocols, and long-term outcomes beyond 30 days.
More on Postoperative Pain
View Original Abstract ↓
Meta-analysis finds systemic lupus erythematosus elevates coronary artery disease risk
People with lupus face higher heart disease risk but genetics show no direct link
Related in Cardiology
From Other Specialties
